CRHBP
CRHBP (corticotropin-releasing hormone-binding protein, also known as CRF-BP or CRFBP) is a secreted protein that binds and inactivates corticotropin-releasing hormone (CRH) and urocortin-1. By doing so it restrains signalling through the hypothalamus-pituitary-adrenal axis. Browse Assay Genie's current range of CRHBP research reagents below, or read on for the biology behind the target.
CRHBP specifically binds and inactivates two hormones: corticotropin-releasing hormone (CRH) and urocortin-1 (UCN). Sequestering these ligands inhibits the hypothalamus-pituitary-adrenal axis and prevents production of corticotropin (ACTH). The protein is therefore a negative regulator of CRH-driven stress-axis activity, acting on the ligand rather than on its receptor. It is a secreted protein and belongs to the CRF-binding protein family.
CRH is a potent stimulator of the synthesis and secretion of preopiomelanocortin-derived peptides. CRH concentrations in the human peripheral circulation are normally low, but they rise throughout pregnancy and fall rapidly after parturition. Maternal plasma CRH probably originates from the placenta. Human plasma contains a CRH-binding protein that inactivates CRH, and this activity may prevent inappropriate pituitary-adrenal stimulation during pregnancy. UniProt likewise notes that the protein may be required for this protective role.
The human CRHBP gene is the source of the protein also called CRF-BP or CRFBP, and its HGNC name is corticotropin releasing hormone binding protein. Orthologous genes, written Crhbp, are annotated in both mouse and rat, so the protein can be studied in common rodent models. Researchers working on the stress axis, placental endocrinology or CRH and urocortin signalling use reagents against CRHBP to follow this regulatory layer.
CRHBP binds and inactivates CRH and urocortin-1, inhibiting the hypothalamus-pituitary-adrenal axis and ACTH production.
CRH rises through pregnancy and falls after parturition, and CRHBP may prevent inappropriate pituitary-adrenal stimulation in this period.
Maternal plasma CRH probably originates from the placenta, making its binding protein relevant to studies of circulating CRH activity.
As a member of the CRF-binding protein family, CRHBP is a model for ligand sequestration of CRH and urocortin-1.
CRHBP is a secreted protein that specifically binds and inactivates CRH and urocortin-1. This inhibits the hypothalamus-pituitary-adrenal axis and prevents ACTH production. It may also be required to prevent inappropriate pituitary-adrenal stimulation during pregnancy, when circulating CRH rises.
The HGNC name is corticotropin releasing hormone binding protein, and UniProt lists corticotropin-releasing hormone-binding protein. Aliases are CRF-BP and CRFBP. These all refer to the same gene and protein, so literature searches should include each name.
Yes. Mouse and rat both have an orthologous gene named Crhbp, so rodent models can be used to study it. Cross-species reactivity differs between reagents, so check the datasheet of any product for its validated reactivity.
Ligands, receptors and pathway partners of CRHBP in stress-axis and pregnancy research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P24387; product specifications from Assay Genie datasheets.